Antiangiogenic VEGF-A in peripheral artery disease.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 25473918.
- Also identified by DOI 10.1038/nm.3767.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Vascular endothelial growth factor A (VEGF-A) is a potent proangiogenic cytokine elevated in patients with peripheral artery disease (PAD). A new study links impaired vascular regrowth in PAD to increased expression of an antiangiogenic splice variant of VEGF-A.
Medical subject headings
- Neovascularization, Physiologic
- Peripheral Arterial Disease
- Vascular Endothelial Growth Factor A